Hisun Specialty Products is dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products for the US, China and additional global markets. We have an expanding pipeline of development candidates within the Oncology, Central Nervous System (CNS) and Cardiovascular therapeutic areas. Hisun is committed to improving the lives of patients through the development of innovative therapies that help serve unmet medical needs. We are striving to achieve meaningful improvements in patient lives.
For more information, please contact:
Peggy Albanese
Vice President Corporation Development
Hisun Pharmaceuticals USA, Inc.
200 Crossing Blvd, 2nd Floor
Bridgewater, NJ 08807
Office: 609-454-0237
Email: Peggy.Albanese@hisunusa.com
